Literature DB >> 21784707

Tigecycline: benefits and risks.

Yun Cai, Rui Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784707     DOI: 10.1016/S1473-3099(11)70183-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

Review 1.  Is it time to move away from polymyxins?: evidence and alternatives.

Authors:  Rajeev Soman; Yamuna Devi Bakthavatchalam; Abinaya Nadarajan; Hariharan Triplicane Dwarakanathan; Ramasubramanian Venkatasubramanian; Balaji Veeraraghavan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-02       Impact factor: 3.267

2.  Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients.

Authors:  Li-Hua Sun; Kun-Hao Bai; Guo-Yan Wu; Xiao-Peng Tian; Zhi-Qing Zou; Da-Wei Wang; Yu-Jun Dai; Si-Liang Chen
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

Review 3.  Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy.

Authors:  Constance Schultsz; Suzanne Geerlings
Journal:  Drugs       Date:  2012-01-01       Impact factor: 11.431

4.  Antimicrobial susceptibility testing and successful treatment of hospitalised patients with extensively drug-resistant Campylobacter jejuni infections linked to a pet store puppy outbreak.

Authors:  Dheeraj Goyal; Louise K Francois Watkins; Martha P Montgomery; Sonya M Bodeis Jones; Hayat Caidi; Cindy R Friedman
Journal:  J Glob Antimicrob Resist       Date:  2021-05-25       Impact factor: 4.349

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.